Main performance indicators
medmix defines and determines its main performance indicators with reference to the Global Reporting Initiative (GRI) Consolidated Set of Standards 2021 and consolidates on an operational control basis.
New acquisitions are integrated into the medmix performance indicator reporting at the start of the subsequent financial year, and are granted a three year period before the defined measures are expected to be achieved. Any site undergoing publicly announced closure activities is excluded from the defined measures while having its performance included in the consolidated results. Consequently, such sites are excluded from the relevant ISO certifications, low-carbon electricity, zero waste to landfill and community engagement commitments.
Measurement of progress and compliance to company commitments are defined in the Applying and Reporting medmix’ Sustainability Commitments guideline.
Whistleblower reports of alleged ethical violations
Indicator | 2025 | 2024 | 2023 | |||
Number of substantiated whistleblower reports | 7 | 4 | 10 |
Substantiated whistleblower reports by category | Reference | Substantiated reports 2025 | ||
Assets | 1 | |||
Business-related | 3 | |||
Corruption | GRI 205 | 0 | ||
Employee-related | GRI 401-406 | 3 | ||
Environmental | 0 | |||
Human rights | GRI 408, 409 | 0 |
Personal data protection
Indicator | 2025 | 2024 | 2023 | |||
Number of confirmed personal data breaches1 | 1 | 0 | 0 |
1)A breach of security leading to the accidental or unlawful destruction, loss, alteration or unauthorized disclosure of or access to personal data transmitted, stored or otherwise processed.
Product safety
Indicator | 2025 | 2024 | 2023* | |||
Number of customer health & safety incidents | 2 | 0 | NA | |||
Number of product recalls | 0 | 1 | NA |
*2023 not currently included.
People
Indicator | Reference | 2025 | 2024 | 2023 | ||||
Management system | ||||||||
% of manufacturing sites certified to ISO 450011 | GRI 403-1 | 100% | 64% | 45% | ||||
Human rights | ||||||||
Number of suspected cases of child, forced or compulsory labor | GRI 408, 409 | 0 | 0 | 0 | ||||
Promote a safe and inclusive workplace | ||||||||
Number of employee work-related fatalities | GRI 403-9 | 0 | 0 | 0 | ||||
Employee recordable injury rate2 | GRI 403-9 | 4.1 | 3.4 | 4.4 | ||||
Employee lost time injury rate2 | GRI 403-9 | 3.1 | 2.2 | 3.2 | ||||
Employee injury severity rate3 | 40.9 | 21.0 | 46.2 | |||||
Environment, health and safety observations | 1’529 | 1’139 | 933 | |||||
Safety walks | 1’698 | 1’594 | 1’348 | |||||
Number of Board of Directors members | 6 | NA | NA | |||||
Number of Board of Directors members who are women | 2 | NA | NA | |||||
Number of Board of Directors members who are over 50 years old | 6 | NA | NA | |||||
Employees (number of full-time equivalents) | 2’574 | 2’684 | 2’658 | |||||
% of employees covered by collective bargaining agreements | 55% | NA | NA | |||||
% of women within management4 | GRI 405-1 | 35% | 34% | 33% | ||||
% of women within workforce | GRI 405-1 | 50% | 46% | 46% | ||||
% of workforce over 50 years old | GRI 405-1 | 27% | 27% | 39% | ||||
Enable learning and employee engagement | ||||||||
Number of employees invited to Learning Lab sessions | 1’998 | 1’800 | 1’500 | |||||
Number of employees onboarded to virtual learning platform | 100 | 100 | 100 | |||||
Number of training hours5 | 3’637 | 2’020 | NA | |||||
% of employees trained to Code of Conduct6 | 93% | NA | NA | |||||
% of sites assessed to living wage benchmarks | 100% | 100% | NA | |||||
Support local communities | ||||||||
Number of community engagement projects | GRI 413-1 | 59 | 60 | 34 |
1)1 site waiting for certificate, having successfully passed the Stage 2 audit during 2025.
2)Per million hours worked, employees only.
3)# of lost workdays per million hours worked, employees only.
4)Management level 5 and above, excluding Board of Directors.
5)Learning Hour sessions + LinkedIn Learning Hours.
6)Code of Conduct training includes whistleblower, anti-corruption, anti-bribery and anti-competition training.
Planet
Indicator | Reference | 2025 | 2024* | 2023* | ||||
|---|---|---|---|---|---|---|---|---|
Management system | ||||||||
% of manufacturing sites certified to ISO 140011 | 100% | 64% | 55% | |||||
% of relevant manufacturing sites certified to ISO 500011 | 100% | 50% | 25% | |||||
Climate change ∆ | ||||||||
medmix-own2 GHG emissions (t CO2e) | GRI 305 | 12’132 | 15’524 | 14’673 | ||||
medmix Scope 1 GHG emissions (t CO2e) | GRI 305-1 | 4’127 | 4’145 | 4’432 | ||||
medmix Scope 2 GHG emissions (t CO2e) | GRI 305-2 | 5’049 | 5’848 | 5’525 | ||||
medmix-own Scope 3 GHG emissions3 (t CO2e) | GRI 305-3 | 2’956 | 5’531 | 4’716 | ||||
Total Scope 3 GHG emissions4,5 (t CO2e) | GRI 305-3 | 53’000 | 57’512 | 59’473 | ||||
Total Scope 1, 2 and 3 GHG emissions4,5 (t CO2e) | GRI 305 | 62’176 | 67’504 | 69’429 | ||||
% reduction in absolute medmix-own2 GHG emissions compared with base year | 60% | NA | NA | |||||
% reduction in absolute Scope 1 and 2 GHG emissions compared with base year (near-term) | 61% | NA | NA | |||||
% reduction in absolute Scope 3 emissions compared with base year (near-term) | 32% | NA | NA | |||||
% reduction in absolute Scope 1, 2 and 3 emissions compared with base year (long-term) | 39% | NA | NA | |||||
% of sites using low-carbon electricity | 100% | 92% | 86% | |||||
Energy consumption (GJ) | GRI 302-1 | 240’036 | 234’685 | 206’594 | ||||
Electricity purchased that is renewable or low-carbon (GJ) | GRI 302-1 | 124’564 | 89’804 | 86’373 | ||||
Energy produced that is renewable electricity (GJ) | GRI 302-1 | 2’423 | 1’569 | 478 | ||||
Total grid electricity consumed (GJ) | GRI 302-1 | 161’091 | 153’284 | 124’937 | ||||
Water stewardship | ||||||||
% of manufacturing sites assessed according to WASH | WRC-WA May 2021 | 100% | 100% | 100% | ||||
Water withdrawal (m3) | GRI 303-3 | 538’590 | 533’512 | 570’473 | ||||
Water consumption (m3) | GRI 303-5 | 11’372 | 20’728 | 18’887 | ||||
Water discharge (m3) | GRI 303-4 | 527’218 | 512’783 | 550’895 | ||||
Waste for disposal | ||||||||
% of sites with zero waste to landfill | GRI 306-3 | 94% | 62% | 50% | ||||
Total waste (t) | GRI 306-3 | 4’802 | 3’798 | 2’464 | ||||
Total non-hazardous waste (t) | GRI 306-3a | 4’749 | 3’737 | 2’397 | ||||
Total hazardous waste (t) | GRI 306-3a | 53 | 61 | 67 | ||||
Non-hazardous waste to recycling (t) | GRI 306-4 | 3’348 | 2’885 | 1’694 | ||||
Hazardous waste to recycling (t) | GRI 306-4 | 9.7 | 31 | 32 | ||||
Non-hazardous waste to preparation for reuse (t) | GRI 306-4 | 48 | 21 | 0 | ||||
Hazardous waste to preparation for reuse (t) | GRI 306-4 | 0.5 | 0.1 | 0.2 | ||||
Non-hazardous waste to incineration with energy recovery (t) | GRI 306-5 | 1’095 | 600 | 605 | ||||
Hazardous waste to incineration with energy recovery (t) | GRI 306-5 | 23 | 21 | 20 | ||||
Non-hazardous waste to incineration without energy recovery (t) | GRI 306-5 | 0 | 2.3 | 0 | ||||
Hazardous waste to incineration without energy recovery (t) | GRI 306-5 | 19.8 | 0.4 | 1.2 | ||||
Non-hazardous waste to other external treatment (t) | GRI 306-5 | 0 | 0 | 0 | ||||
Hazardous waste to other external treatment (t) | GRI 306-5 | 0 | 7.8 | 9.0 | ||||
Total waste to landfill (t) | GRI 306-5 | 258 | 230 | 103 | ||||
Non-hazardous waste to landfill (t) | GRI 306-5 | 258 | 229 | 98 | ||||
Hazardous waste to landfill (t) | GRI 306-5 | 0 | 0.3 | 4.5 |
∆Emissions reported according to the latest Greenhouse Gas Protocol Corporate Accounting and Reporting Standard. Data is calculated from meter readings, invoices and supplier reports. Where actual data is not available, estimations are made based on, but not limited to, previous trends. Scope 1 includes emissions from stationary combustion sources and medmix-owned or controlled mobile combustion sources, as well as refrigerant leakage and the use of dry ice. Scope 2 emissions for grid electricity are calculated according to the market-based method. Standard conversion factors applied from the latest DEFRA and IEA publications and the EcoInvent database.
*2024 and 2023 climate change restated according to Greenhouse Gas Protocol requirements concerning acquisitions.
1)1 site waiting for certificate, having successfully passed the Stage 2 audit during 2025.
2)Scope 1, 2 and partial 3 (upstream categories 3 and 6).
3)Scope 3 upstream categories 3 and 6.
4)Scope 3 upstream categories 1 to 8.
5)Due to the complexity and extensive data collection required for Scope 3 emissions, we are currently in the process of calculating the 2025 figure. An initial estimation based on known changes to revenue is provided, and the final result will be published once it is known.
Profit
Indicator | Reference | 2025 | 2024 | 2023 | ||||
Increase sales of sustainable products | ||||||||
Number of products launched meeting definition of sustainable1 | 15 | 20 | 20 | |||||
Gold standard recognition | ||||||||
medmix CDP Climate Change score | B | A | B | |||||
medmix CDP Water Security score | B | A- | NA |
1) Minimum of 30% reduction in CO2e cradle-to-gate compared with standard product or meeting eco-designed definition.